CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for AMI Organics Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

AMI Organics Ltd
Plot No. 440/4, 5 & 6, Road No. 82/A
Phone: +91 7573015366p:+91 7573015366 SURAT, 394230  India Ticker: AMIORGAMIORG
Business Summary
Ami Organics Limited is an India-based manufacturer of pharma intermediates and specialty chemicals. The Company is focused on the development and manufacturing of advanced pharmaceutical intermediates (Pharma Intermediates), New Chemical Entities (NCE) and other specialty chemicals for pharmaceuticals, agrochemicals, dyes, polymers, personal care, animal food, and other Industries. It manufactures pharma intermediates for certain active pharmaceutical ingredient (APIs), including dolutegravir, trazodone, entacapone, nintedanib, and rivaroxaban. The pharma intermediates cater to several therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. The Company has developed and commercialized over 520 plus products including specialty chemicals, Pharma Intermediates for APIs across 23 key therapeutic areas since inception and NCE across select high-growth high margin chronic therapeutic areas.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20243/31/2024Yes----

Industries
SIC Code Description
2819 Industrial inorganic chemicals, not elsewhere classified
2869 Industrial organic chemicals, not elsewhere classified
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board, Managing Director Nareshkumar R.Patel 50 1/1/2022 1/1/2022
Chief Financial Officer Bhavin N.Shah 6/1/2022 6/1/2022
Chief Information Security Officer ChetansinhParmar 8/12/2024 8/12/2024
8 additional Officers and Directors records available in full report.

Business Names
Business Name
543349
AMIORG

General Information
Number of Employees: 676 (As of 3/31/2024)
Outstanding Shares: 40,934,461 (As of 10/14/2024)
Shareholders: 97,171
Stock Exchange: NSE
Fax Number: +91 261757301536


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024